68Ga-NNS309
CGCJ904A12101
Phase 1 small_molecule active
Quick answer
68Ga-NNS309 for Pancreatic Ductal Adenocarcinoma is a Phase 1 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active